Clinical Trial Software Development Services

There are three viable paths. If your trial runs a standard protocol, an off-the-shelf CTMS is usually faster and cheaper. If it has non-standard workflows or unusual integrations, custom development pays off over the trial's lifecycle. Many sponsors land on a hybrid: an off-the-shelf core for standard operations, with custom modules built where the platform falls short, giving you speed where you don't need customization and control where you do. Relying too heavily on one vendor can also create long-term flexibility issues as requirements, integrations, or pricing change.

Custom clinical trial software typically takes 3 months to 2 years or more, depending on how many eClinical modules are in scope and how many systems it needs to integrate with. A single-module build, like a standalone EDC system, takes less time than a full CTMS-to-eTMF-to-EDC integrated stack. Regulatory validation adds time beyond core development, not instead of it.

Custom CTMS development typically costs $150,000 to $500,000, depending on the number of modules, integration complexity, project management, and validation requirements. A single-module MVP costs less than a fully integrated system connecting CTMS, EDC, and eTMF. Off-the-shelf CTMS platforms carry lower upfront cost but ongoing licensing fees that can exceed custom development cost over a multi-year trial.

Yes, we build integrations using FHIR and HL7, the interoperability standards most major eClinical and EHR platforms support, which allows connection to a range of existing systems.

Yes. We build audit trails, electronic signature workflows, and access controls into the system architecture to meet FDA 21 CFR Part 11 requirements.

Yes, we sign Business Associate Agreements (BAA) for HIPAA-regulated data. A BAA is required whenever a vendor handles protected health information on a covered entity's behalf, which applies to most clinical trial data involving identifiable patients.

eClinical software is the category of digital systems used to plan, run, and document a clinical trial, including CTMS, EDC, RTSM, eTMF, eCOA, and eConsent tools. These platforms are revolutionizing clinical trials and advancing clinical research by replacing paper-based processes with electronic records that regulators can audit under FDA 21 CFR Part 11. Most trials run several eClinical systems together, connected through integrations, rather than one all-in-one product.

A CTMS, also called a clinical trial management system, is a software system that centralizes trial planning, site management, budgeting, and regulatory tracking for a clinical trial, helping support clinical trial operations and Good Clinical Practice.

RTSM (randomization and trial supply management), also called IRT (interactive response technology), is a system that manages patient randomization and drug supply logistics across trial sites.

EDC (electronic data capture) software is a system that collects, validates, and stores clinical trial data directly from investigative sites, replacing paper case report forms.

eTMF (electronic trial master file) software is a system that stores and organizes the documents regulators require to reconstruct a trial's conduct after the fact.

eCOA (electronic clinical outcome assessment) software is a system that captures patient-reported, clinician-reported, and observer-reported outcome data electronically during a trial.

eConsent software is a system that delivers informed consent information to trial participants electronically and captures their consent with a verifiable digital signature.

A DCT (decentralized clinical trial) platform is a system that lets patients complete some or all trial activities remotely through telemedicine visits, wearables, at-home data collection, and related healthcare services instead of requiring only in-person site visits.